Skip to content

Randomized Controlled Trial of Treating Migraine With Acupuncture

Randomized Controlled Trial of Treating Migraine With Acupuncture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00599586
Enrollment
480
Registered
2008-01-24
Start date
2007-11-30
Completion date
2009-09-30
Last updated
2010-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

migraine, acupuncture, efficacy, safety, meridian, acupoint

Brief summary

The purpose of the study is to testify whether acupuncture is effective for migraine, and provide evidence for the hypothesis thatAcupuncture effect is based on meridians, and gathering of meridian Qi is the key point.

Detailed description

The purpose of the study is to testify whether acupuncture is effective for migraine, through treating migraine patients for a month, using different acupoints according to literatures of treating migraine with acupuncture, and try to provide clinical evidence for the hypothesis thatAcupuncture effect is based on meridians, and gathering of meridian Qi is the key point.

Interventions

OTHERacupuncture

Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Age of a subject is older than 18 and is younger than 65.(The subject is younger than 50 when he was ill for the first time.) 2. Consistent with the diagnostic criteria of Premonitory Migraine and Non- Premonitory Migraine. 3. Attacks of migraine are equal to or more than 2 times in the last three months. 4. With more than one year history of migraine 5. Informed consent is signed by a subject or his lineal relation.

Exclusion criteria

1. With serious protopathy or disease of cardiovascular, liver, renal,gastrointestinal, hematological systems and so on. 2. Psychotic,patients with allergic constitution or easily getting infected or bleeding. 3. Patients have used drugs for preventing migraine in the last four weeks. 4. Pregnant women or women in lactation.

Design outcomes

Primary

MeasureTime frame
number of days with migraine4 weeks
frequency of migraine attacks4 weeks

Secondary

MeasureTime frame
Migraine-Specific Quality-of-Life Questionnairea month
Transcranial Doppler Sonographya month

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026